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Abstract
The challenges posed by the ongoing COVID-19 pandemic have required the introduction of new care delivery models
and procedures. For the foreseeable future, vaccine administration will be a key part of the patient experience journey. It
is important therefore to understand and evaluate experiences of individuals taking the vaccination, an area which
requires considerable attention. To address this, the COVID-19 Vaccination Satisfaction survey was developed and
administered at several healthcare facilities across Saudi Arabia. Between January 2021 and end of December 2021, a
total of 1,699,177 completed surveys were collected. The survey results suggest high satisfaction among participants
taking the vaccine; however, satisfaction with information and communication about the vaccine was relatively low.
Results from this survey are updated daily and provide unique insights into the key strengths of the vaccination process,
as well as aspects within the process that require improvement.
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Introduction
The ongoing COVID-19 pandemic has had considerable
impact on society requiring unprecedented efforts being
devoted to development and administration of vaccines
against the virus. In the absence of treatments for the
disease, vaccines arguably remain the most effective means
to control and prevent the spread of the virus.1,2
Vaccination programs across the world are also considered
an effective way to reduce the severe effects of the virus
and preventing hospitalizations3 which can add significant
pressure on a country’s healthcare system.
Despite the adverse effects of the pandemic on society,
acceptance of the vaccine is not considered universal.2,3
Concerns about vaccine hesitancy are growing across the
world,4-6 with several reasons cited for this hesitancy
including but not limited to fear of vaccine content, fear of
side-effects, and little information about the vaccine.7 It is
widely acknowledged that that the success of the vaccine
against the virus hinges greatly on the uptake of the
vaccine itself.8,9 However, a study by Larson et al.10 has
shown that vaccine hesitancy is variable across the globe,
with the European region having the least confidence in
vaccine safety. The study also noted that there was a gap
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between confidence in the importance of vaccination,
which was high, and confidence in vaccination safety,
which was low.
In Saudi Arabia, uptake of the vaccine was expected to be
low. Past research on the uptake of the influenza vaccine
in Saudi Arabia suggested lower vaccine uptake11 whereas
recent research in Saudi Arabia also indicated high levels
of vaccine hesitancy, particularly among young adults,
within the Kingdom.12
Nonetheless, the ongoing nature of the pandemic means
that for the foreseeable future, vaccinations will be an
integral part of the patient experience. Given the
importance of vaccination and the challenges around its
administration, understanding the perception and
satisfaction of the vaccination process, and obtaining
feedback from the public is vital. Despite significant
advancements being made against the pandemic,
understanding the public’s satisfaction with the vaccination
process itself has received very little attention.3,7 Recent
studies that have assessed patient satisfaction with
COVID-19 vaccination program, though important and
much needed, have either been conducted at a single
hospital,13 or for a specific target population.3 There
remains a need to understand the experience and
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satisfaction of users with the vaccination process,
therefore, this study aims to address this gap by reporting
the development, administration and results of the
national COVID-19 Vaccination Satisfaction survey in
Saudi Arabia.

COVID-19 Vaccination Program in Saudi Arabia

Kingdom of Saudi Arabia took a proactive approach to
vaccine administration in the Kingdom. Following the
approval of the Pfizer/BioNTech vaccine by World
Health Organization (WHO), the vaccine was also
approved for administration in the Kingdom by the Saudi
Food and Drug Authority in December 2020. Since then,
the Ministry of Health (MOH) has taken several steps to
ensure efficient vaccine roll-out within the Kingdom. As a
first step, the MOH launched Riyadh Expo as the first
vaccination center in the Kingdom in December 2020,
followed by Launch of Jeddah Airport in the same month.
By February 2021, MOH had expanded its vaccination
operations to all regions in the Kingdom and across all
sectors (MOH and non-MOH). Due to the efforts of the
MOH, by May 2021, 10 million vaccines had been
administered. As of 2nd January 2022, over 51 million
doses of the approved vaccines have been administered
within the Kingdom.
The COVID-19 vaccination program was rolled-out in
three phases in Saudi Arabia. During the first phase,
registration for vaccination was available to those aged
over 65 years and those who had chronic ailments or were
at a high risk of infection. During the second phase, which
began on 18th February 2021, vaccination registration was
available for those aged 50 and over and those with
chronic ailments or high risk of infection Health
practitioners also continued to receive vaccinations during
this phase. During phase 3, vaccination was offered
everyone else. Registration for the vaccination program
was done via a dedicated booking app. Vaccinations are
being provided free of cost to both Citizens and Residents
in the Kingdom. In line with the WHO guidelines, four
vaccines are currently approved for administration in Saudi
Arabia. These include:
•
•
•
•

Pfizer-BioNtech (2 dose)
AstraZeneca (2 dose)
Moderna (2 dose)
Johnson and Johnson (1 dose)

Vaccine administration continues to be a priority in the
Kingdom and across the globe especially due to the
evolving nature of the COVID-19 virus. Vaccine
administration at this scale and pace is unprecedented, but
nonetheless is now an integral part of patient experience
going forward. It is important therefore that the
experience of those taking the vaccine is captured to aid
with quality improvement initiatives and implementation
of person-centered care in such procedures.
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Methodology
Survey Design and Development

The COVID-19 vaccination satisfaction survey was
designed to capture key information about the experience
of individuals taking their vaccination. To ensure
robustness, the survey development underwent several key
stages. As a first step, it was important to understand the
journey of individuals taking their vaccination (journey
analysis). This involved a collaborative effort with key
stakeholders at the MOH to map a typical journey from
registering for a vaccination appointment through to
receiving vaccine administration. As part of this process,
the current challenges being faced by the MOH during the
vaccination process were also noted as well as their
expectations from the survey. Following this, a series of
questions were drafted to capture the experience of taking
the vaccination across the journey. The questions were
adapted from validated patient experience surveys
routinely administered by Press Ganey® given that prior
surveys aiming to capture such information were not
available.
A first draft of the survey was completed and discussed
with key stakeholders at MOH for feedback. After this, the
survey was finalized and prepared for administration. The
final survey consisted of 18 questions within four domains:
Booking Application, Access, Vaccination and Overall
Assessment (see Table 1). Prior to testing, individuals
utilized MOH’s Sehhaty App to schedule vaccination
appointments. The first domain of the survey therefore
covers user experience of using these applications. The
second domain allows respondents to rate the experience
of accessing the vaccination centers. The third domain
asks respondents about their experience of vaccine
administration while the fourth domain asks those taking
the vaccine to provide an overall assessment of their
experience. The survey also included an additional openended question to allow participants to provide any further
feedback about their experience. The survey was made
available in Arabic and English languages.

Survey Administration and Data Collection

A key aspect of the MOH vaccination program is a unified
repository for all relevant information integrated with the
dedicated booking app. All public and private vaccine
centers use the same platform and all data collected is
stored in the National Health Observatory (NHO). The
collected data is verified through established government
systems using linked national IDs and verified phone
number of those receiving the vaccine.
A unified central system allowed for efficient survey
administration throughout the Kingdom. Everyone taking
the vaccination was sent a SMS link to their verified phone
number to complete the survey. This link is unique to the
respondent and only accessible to the respondent
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Table 1. List of Survey Domains and Associated Questions
Domain
Booking application
Access

Vaccination

Overall assessment

Questions
Ease of the registration and login
Ease of using the application and registering for vaccination
Ease of reaching the vaccination center through the location link
Courtesy of the registration staff
Ease of the registration process
Waiting time before entering the vaccination room
Comfort of the waiting area
Staff explanation of the vaccination procedure
Staff response to your questions and worries
Concern shown for your comfort when giving you the vaccine
Information given about what to expect after vaccination and how to report any adverse events
Courtesy and respect of vaccination center’s staff
Our concern for your privacy during vaccination
Staff efforts to protect your safety during vaccination (i.e. wearing masks and gloves and following
infection control measures)
Cleanliness of the vaccination center
How well staff worked together to provide your vaccine
Overall rating of your vaccination experience
Likelihood of recommending the vaccination program to others

therefore reducing duplications. Participants are free to
choose whether they would like to complete the survey.
Once the survey is completed and submitted, data is
collected centrally for monitoring and analysis. During this
process, strict data collection protocols are followed to
ensure privacy of survey participants is maintained. The
survey was also tested for validity and reliability to ensure
robustness of results.
To support effective decision making using this
information, the PX Connect dashboard was used. This
dashboard helps in tracking survey operations, check
engagement rates and follow-up on survey results daily.
The dashboard covers both, quantitative and qualitative
information to provide a complete picture of participant’s
experience of the vaccination process. Live reporting of
results in this way allows immediate actions to be taken on
quality improvements. For this paper, data collected from
January 2021 to December 2021 was used.

Data Analysis and Validation

A descriptive analysis was performed on the collected data
using IBM SPSS 26 software. Where required, one-way
ANOVA was also used to determine differences between
groups. Each of the survey questions was rated by
respondents on a five-point Likert scale from Very Poor to
Very Good. For analysis, the response scale was converted
into a numeric scale (see Table 2) in line with the
established methodology used by Press Ganey®14 to
facilitate interpretation of collected data. This document is
available by contacting Press Ganey®. The main measure
for the survey, Vaccination Satisfaction Score was
calculated by taking the average of the means of each of
the survey domains at the participant level. Calculating the
satisfaction score in this way ensures that equal weightage
is given to each of the survey participants.
Sentiment analysis was used to analyze the open-ended
questions. Three coders independently reviewed each
comment and manually assigned a sentiment label to the
comments based on the criteria set out in Table 3. Once
the assignment was complete, it was cross checked for

Table 2. Press Ganey® Converted Values
Survey response
Very Poor
Poor
Fair
Good
Very Good

Likert scale value
1
2
3
4
5

Patient Experience Journal, Volume 9, Issue 3 – 2022

Converted value
0
25
50
75
100
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Table 3. Sentiment Coding Criteria
Sentiment
Positive
Negative
Mixed
Neutral

Criteria
Agreeable/complimentary remarks highlighting a positive experience
Disagreeable/complaining remarks which stipulate improvement
Contain both positive and negative remarks
A statement of fact that includes neither a compliment nor a complaint

consistency and any disagreement was settled following
discussions.
Confirmatory factor analysis (CFA) was used to evaluate
the construct validity of the survey using the fit indices;
comparative fit index (CFI), Tucker-Lewis index (TLI) and
standardized root mean square residuals (SRMR).15
Reliability of the survey was tested using Cronbach Alpha
scores. Convergent validity was evaluated using average
variance extracted (AVE).15,16

Results

Cronbach alpha scores for all domains were above 0.7
demonstration good internal consistency. Results of the
CFA indicate an acceptable construct validity (CFA=0.86,
TLI=0.83 and SRMR=0.06). Factor loadings for all items
were found to be above 0.7 except for Item Q3—Ease of
reaching the vaccination center through the location link
(0.497). The AVE scores for all constructs were above 0.5
therefore supporting good convergent validity of the
survey.

Overall Satisfaction Scores

Overall, the vaccine satisfaction scores were high across all
three sectors (see Table 6).

Participants

During 2021, a total of 23,734,595 surveys were
conducted. From these, responses were recorded from
3,909,431 (16.47%) participants. 1,699,177 (43.4%) of
these surveys were considered complete. Table 4 provides
a breakdown of respondents based on the sector, type of
facility where vaccination was received, residency status and
dose.

Reliability and Validity

Table 5 provides a summary of the Cronbach Alpha scores
for the survey domains and the overall survey.

Participants vaccinated at MOH facilities reported higher
satisfaction scores, on average, compared with facilities at
other sectors. Similarly, across facility types, reported
satisfaction was relatively high, although there was some
variability in scores.
Participants vaccinated at MOH premium centers reported
the highest satisfaction scores (see Table 7) compared with
other facility types.
Among MOH facilities, satisfaction scores for primary
health centers (PHCs) were lowest (on average).

Table 4. Breakdown of Participants

Sector

Service type

Residency
Dose
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MOH
Non-MOH
Military
Not known
Hospital
PHC
Premium center
Vaccine center
Pharmacy
Not known
Citizen
Resident
Not known
First
Second
Not known

N
1,460,152
125,209
113,420
396
417,710
279,597
627,760
366,187
5,697
2,226
1,030,468
386,544
282,165
1,295,007
401,857
2,313

%
85.9%
7.4%
6.7%
0%
24.6%
16.5%
36.9%
21.6%
0.3%
0.1%
60.6%
22.7%
16.6%
76.2%
23.7%
0.1%
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Table 5. Survey Cronbach Alpha Scores
Domain

Item

Alpha

Booking
Application

Access

0.677
0.677
0.826

Ease of reaching the vaccination center through
the location link
Courtesy of the registration staff
Ease of the registration process
Waiting time before entering the vaccination room
Comfort of the waiting area

Overall

Alpha if
item
deleted

0.804
Ease of the registration and login
Ease of using the application and registering for
vaccination

Vaccination

Corrected
item-total
correlation

Staff explanation of the vaccination procedure
Staff response to your questions and worries
Concern shown for your comfort when giving you
the vaccine
Information given about what to expect after
vaccination and how to report any adverse
events
Courtesy and respect of vaccination center’s staff
Our concern for your privacy during vaccination
Staff efforts to protect your safety during
vaccination
Cleanliness of the vaccination center
How well staff worked together to provide your
vaccine
Overall rating of your vaccination experience
Likelihood of recommending the vaccination
program to others

Satisfaction scores for PHCs were also low among nonMOH healthcare facilities.
Across all three sectors, overall satisfaction scores
remained high for participants taking their first and second
doses (Table 8), and among citizens and residents of Saudi
Arabia (Table 9)

Key Strengths and Areas for Improvement

Table 10 provides a summary of the mean scores for each
of the questions on the survey. The mean scores were high

0.903

0.918

0.449

0.836

0.685
0.644
0.676
0.685

0.779
0.786
0.776
0.774

0.787
0.821
0.800

0.885
0.878
0.881

0.730

0.894

0.695
0.692
0.644

0.893
0.893
0.897

0.622

0.900

0.789

0.917

0.877
0.839

0.847
0.878

across all questions suggesting high satisfaction levels
among participants. In particular, participants were very
satisfied with the cleanliness of the vaccination center,
staff efforts to protect participant’s safety during the
vaccination process and courtesy of the registration staff at
the vaccination center. For all three of these questions,
majority of the participants (>89%) gave a rating of very
good.
In contrast, the lowest average scores were recorded for
questions regarding information and communication about

Table 6. Overall Satisfaction Scores by Sector

MOH
Non-MOH
Military

N
1,460,144
125,209
113,420

Patient Experience Journal, Volume 9, Issue 3 – 2022

Mean satisfaction score
92.80
90.84
91.94

Standard deviation
13.86
16.23
15.89
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Table 9. Overall Satisfaction Scores by Facility Types within Sectors

MOH

Non-MOH

Military

Service type
Hospital
PHC
Premium center
Vaccine center
Pharmacy
Hospital
PHC
Vaccine center
Pharmacy
Hospital

N
221,929
276,157
627,760
332,608
104
82,361
3,440
33,579
5,593
113,420

Mean satisfaction score
91.08
89.44
95.8
91.1
90.13
90.77
89.32
91.5
89.27
91.95

Standard deviation
15.41
17.17
9.41
15.52
17.69
16.05
17.07
16.2
17.76
15.89

Table 8. Overall Satisfaction Score by Dose within Sectors
Sector
MOH
Non-MOH
Military

Dose
First
Second
First
Second
First
Second

N
1,119,492
340,660
83,655
39,241
91,570
21,850

Mean satisfaction score
92.46
93.90
90.90
90.51
92.31
90.43

Standard deviation
13.84
13.93
15.82
17.28
15.17
18.53

Table 7. Overall Satisfaction Score by Residency Status within Sectors
Sector
MOH
Non-MOH
Military

Residency
Citizen
Resident
Citizen
Resident
Citizen
Resident

N
924,210
336,271
56,991
33,177
49,119
16,956

the vaccination process. Information given about what to
expect after vaccination and how to report any adverse
events was the lowest rated question by participants across
all three sectors, followed by staff explanation of the
vaccination procedure and staff response to your question
and worries. Among facility types, the average rating for
these three questions was lowest among participants
vaccinated at PHCs (Figure 1).
As part of the survey, participants were also asked about
their likelihood of recommending the vaccination program
to others. Majority of the participants (n=1,317,722) gave
the highest rating (Very Good), suggesting they were
highly likely to recommend the vaccination program to
others. When considering facility type, participants
vaccinated at premium centers had a significantly higher
score for likelihood of recommending the vaccination
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Mean satisfaction score
93.60
92.38
90.92
91.43
91.54
91.87

Standard deviation
13.35
13.16
16.97
14.53
16.54
14.69

program compared with other facilities (mean=98.23,
p<0.01). PHC again had the lowest average scores for
likelihood to recommend (mean=89.96, p<0.01).

Participant’s Comments

The survey also encouraged participants to provide any
other feedback about the vaccination process through
open ended questions. A total of 510,756 comments were
received from participants during 2021. Majority of the
vaccination recipients were highly complementary of the
vaccination program. Sentiment analysis shows that a high
concentration of comments received from the participants
were positive (Figure 2).
Participants were very complimentary about the
vaccination process in general.

Patient Experience Journal, Volume 9, Issue 3 – 2022

Satisfaction with COVID-19 vaccination program, Shahzad et al.

Table 10. Item Level Descriptive Statistics
Survey questions

N

Mean

Ease of the registration and login
Ease of using the application and registering for vaccination
Ease of reaching the vaccination center through the location link
Courtesy of the registration staff
Ease of the registration process
Waiting time before entering the vaccination room
Comfort of the waiting area
Staff explanation of the vaccination procedure
Staff response to your questions and worries
Concern shown for your comfort when giving you the vaccine
Information given about what to expect after vaccination and how
to report any adverse events
Courtesy and respect of vaccination center’s staff
Our concern for your privacy during vaccination
Staff efforts to protect your safety during vaccination (i.e. wearing
masks and gloves and following infection control measures)
Cleanliness of the vaccination center
How well staff worked together to provide your vaccine
Overall rating of your vaccination experience
Likelihood of recommending the vaccination program to others

1,152,452
1,159,585
1,499,107
1,647,566
1,647,772
1,651,658
1,643,137
1,568,250
1,577,394
1,596,652
1,578,155

91.81
90.01
94.85
95.62
94.15
93.29
92.48
83.78
88.49
92.12
83.27

Standard
deviation
19.86
22.02
15.75
15.12
16.95
18.86
19.98
28.61
23.99
20.00
29.57

1,603,834
1,599,903
1,602,595

94.94
94.82
95.87

16.08
16.08
14.45

1,592,296
1,504,854
1,513,092
1,510,767

96.29
94.41
94.45
94.45

13.17
16.27
16.08
17.25

“I experienced an excellent hospitality throughout the vaccination
process and the swift working skill with proper care and safety. Keep
up the good work team.”
Participants were also very complementary of the staff,
“Very good treatment by staff at vaccination center and very good
application for registration.”
The overall positive sentiment of participants meant that
they were happy recommend vaccination to others as well.
“Excellent experience very well organized and excited to recommend
to my friends to go ahead and get vaccinated as soon as possible.”
The negative comments received from participants were
mostly about the information and communication
regarding the vaccination procedure. Participants
expressed their dissatisfaction with not being provided
sufficient information about the symptoms and side
effects of the vaccine.
“To stress upon the side effects that may happen following vaccination
and how to treat…”
“Not informed regarding need of updating post vaccination side effects
in the Sehhaty app.”

Discussion
Measuring patient experience is an integral part in
improving the quality of health services provided to

Patient Experience Journal, Volume 9, Issue 3 – 2022

patients. With the ongoing pandemic, vaccine
administration can be considered a new patient experience
journey making it necessary to understand the experience
of those undergoing the vaccination process. This study
documents a first of its kind national survey developed
and administered in the Kingdom of Saudi Arabia to
capture the experience and satisfaction of the public with
the vaccination process.
The results of the survey are encouraging. Overall,
participants reported high satisfaction levels with the
vaccination process and were highly complementary about
their experience. In particular, participants were highly
satisfied with the cleanliness of the vaccination centers, the
efforts made by vaccination center staff to protect their
safety by using the appropriate personal protective
equipment, and the courtesy of the registration staff.
On the other hand, satisfaction among participants was
relatively lower with questions relating to information and
communication about the vaccination program. This result
is consistent with previous studies; in a satisfaction survey
of people hospitalized with COVID-19 in Liverpool,
United Kingdom, Wu et al.13 found that information about
medication and side effects had the lowest satisfaction.
Similarly, a study by Algado-Selles et al.3 on satisfaction
with COVID-19 vaccination program among teaching
staff in General University Hospital of Alicante found that
‘information offered prior to the vaccine’ and ‘information
provided before attending the facilities for vaccination’
were rated low by participants. Information and
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Information given about what to
expect after vaccination and how
to report any adverse events
Hospital

PHC

Staff explanation of the
vaccination procedure
Premium Center

83.74

86.15

93.54

83.07

86.35

77.81

80.59

90.15

77.2

81.08

77.18

80.23

89.47

77.09

100
90
80
70
60
50
40
30
20
10
0

80.46

Figure 2. Average Scores by Facility Type

Staff response to your questions
and worries

Vaccine Center

Pharmacy

Figure 1. Sentiment Analysis
90.0%
80.0%
70.0%
60.0%
50.0%
40.0%
30.0%
20.0%
10.0%
0.0%

80.6%

9.4%

Positive

Negative

communication about the vaccine are important factors. A
study by Di Gennaro et al.7 found that lack of information
about the vaccine is a contributing factor towards vaccine
hesitancy. In the current survey, a simple Pearson
correlation between the three information questions and
the likelihood of recommending vaccination to others was
positive and statistically significant (p<0.01). This suggests
that a higher overall satisfaction will result in more people
recommending the vaccination program to others. The
current pandemic is unprecedented and unsurprisingly can
lead to anxiousness among the public. Given the growing
concerns around vaccine hesitancy, it is important that any
concerns raised by those taking the vaccine are alleviated
and a good level of explanation about the vaccination
procedure, both before taking the vaccine and after the
vaccine has been administered, is provided21. Comments

161

2.2%

Mixed

7.8%

Neutral

from survey participants suggested they felt there was lack
of information about the vaccine side effects and
information about next steps that can be taken in case of
any issues following vaccination. Such concerns, at a basic
level, can be alleviated by providing those taking the
vaccine with information leaflets that clearly lay out what
to expect during the vaccination procedure and provide all
the necessary contact details to use in case there are any
issues following vaccination. Informational concerns about
the vaccine must also overcome the misinformation and
disinformation about the vaccine, which is known to
promote vaccine hesitancy.22 Therefore, careful planning
on how information about the vaccine can be effectively
and reliably disseminated is required to overcome this
challenge. Nonetheless, it is important that healthcare
providers respond promptly to concerns raised by those

Patient Experience Journal, Volume 9, Issue 3 – 2022
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taking the vaccine and direct them towards reliable sources
of information.

communicate all key information about the vaccine and
how to report any symptoms post vaccination clearly.

Overall satisfaction levels were also high at various
facilities. While premium centers, setup specifically for
vaccine administration, recorded the highest satisfaction
levels among participants, PHC recorded the lowest. This
result was somewhat expected; public opinion about PHC
is generally low in Saudi Arabia and past studies have
suggested that the general public often seeks to bypass
PHC and access secondary care directly.17 Studies have
noted that PHC centers have lacked sufficient equipment18
and have lower levels of patient satisfaction.19 More
recently, a study by Caswell and Kenkre17 found five key
areas of concern: communication, poor environment, lack
of streamlining and flow, lack of unified governance for
nursing staff and inadequate training support for nurses
and physicians.

The COVID-19 pandemic is unprecedented, and the
uptake of vaccine has had some resistance globally. It is
important therefore, that any concerns raised by those
taking the vaccine are alleviated and a good level of
explanation about the vaccination procedure, both before
taking the vaccine and after the vaccine has been
administered, is provided. It is also important to
continuously monitor the results of the survey on an
ongoing basis so that appropriate actions can be taken to
improve patient experience.

Nevertheless, the results from the survey are
overwhelmingly positive during 2021. However, these
results are from a very early stage of the pandemic and
past research has shown that during a pandemic,
enthusiasm for vaccine can be high, especially immediately
before and after a new vaccine is released.20 It is therefore
important to continuously monitor the trends in
satisfaction rates so that appropriate actions can be taken
to improve patient experience.

Conclusion
The COVID-19 vaccination satisfaction survey is a firstof-its-kind global survey implemented in Saudi Arabia.
This survey aims to facilitate continuous improvements in
patient experience by learning from key insights provided
by Saudi residents undergoing vaccination administration.
The survey therefore plays a significant role in supporting
person-centered care by capturing valuable information
about the vaccination process, in particular, the key
strengths of the process and areas requiring improvement.
The current results of the survey show a very high
satisfaction level among individuals taking their
vaccination. Satisfaction levels were particularly high at
premium vaccination centers and across all regions. The
key areas of strength of this program were (i) cleanliness of
the vaccination center, (ii) staff’s efforts to protect your
safety during vaccination (i.e., wearing masks and gloves
and following infection control measures), and (iii) the
courtesy of the registration staff. Nevertheless, the survey
also highlighted three key areas for improvement: staff
explanation of the vaccination procedure, information
given about what to expect after vaccination and how to
report any adverse events, and staff response to your
question and worries. Improvements can be made in these
areas by ensuring that a consistent approach is taken to
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